Using nickel clusters to selectively cleave C=C bonds!
Congratulations to Ph.D. student Manar Shoshani and Prof. Sam Johnson on the publication of their work on the use of pentanuclear nickel clusters for the selective cleavage of C=C bonds in alkenes! These clusters are selective in that they do not attack functional groups, and operate to give quantitative yields at temperatures down to −30 °C!
Click here for more information on Prof. Johnson's research.
See the original article at this link!
Carbons and hydrogens associated with the phosphine ligands and disorder of C(9) and C(10) are omitted for clarity. This 72-electron [Ni5]6+ cluster reveals the triple C–H bond activation of one styrene vinyl moiety, shown in blue, which is coordinated to all five nickel centres prior to C–C cleavage. Two iPr3P groups are replaced by a coordinated styrene moiety, shown in red.
Seminar: Dr. Preston Chase (Green Centre Canada)
UWinChemBiochem Seminar Series - Fall 2017
Dr. Preston Chase
Director of Academic Business Development
Green Centre Canada
https://www.greencentrecanada.com/about-us/people/commercial/preston-chase/
Title: Development and Commercial Application of Novel Catalyst and Forward Osmosis Technologies
Thursday, Nov. 9, 2017 @ 3:00 p.m.
Room 311 Memorial Hall
**Everyone Welcome**
***Note special seminar day and time***
Abstract:
Progressing academic research from the initial invention discovery at the bench to industrial application requires significant efforts, including, for example, scaling of materials for testing, development and validation of new systems of a base technology, and optimization of processes. GreenCentre Canada is a Centre of Excellence for Commercialization and Research in the area of Green Chemistry, providing facilities for both academic and industrial partners to evaluate, develop and ultimately find commercial application for novel Green chemical technologies.
To highlight the path towards industrial applications, three projects that have been advanced at GreenCentre will be presented: the development and scale-up of highly active ester hydrogenation catalysts, the immobilization of a number of homogeneous catalysts for application in flow reactors directed to pharmaceuticals generation, and the development and process optimization of a low energy forward osmosis process. Each will have the contribution of the original inventors and additional efforts of GreenCentre to directly address specific industry-based challenges highlighted.
